(ADUS) Addus HomeCare - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0067391062
ADUS EPS (Earnings per Share)
ADUS Revenue
ADUS: Personal Care, Hospice Care, Home Health Services
Addus HomeCare Corporation is a leading provider of home care services in the United States, catering to the growing demand for non-medical and medical assistance among the elderly and individuals with chronic illnesses or disabilities. The companys diversified service portfolio spans across three key segments: Personal Care, Hospice, and Home Health, allowing it to address a wide range of client needs and capitalize on emerging trends in the healthcare industry.
The Personal Care segment is a significant contributor to the companys revenue, offering essential non-medical services such as bathing, grooming, and meal preparation. The Hospice segment provides critical palliative care services to terminally ill patients, while the Home Health segment delivers skilled nursing and therapy services to individuals recovering from illnesses or hospitalizations. By serving federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals, Addus HomeCare Corporation has established a robust client base and diversified revenue streams.
From a technical analysis perspective, the stock has demonstrated a strong upward trend, with a current price of $114.03 and a 20-day SMA of $112.72, indicating a potential buying signal. The 50-day SMA at $106.87 further supports this bullish outlook, while the 200-day SMA at $117.40 suggests a potential resistance level. With an ATR of 3.16, representing a 2.77% daily volatility, traders can anticipate moderate price movements. Given the current technical setup, a potential price target could be $125.00, representing a 9.6% upside from current levels.
Fundamentally, Addus HomeCare Corporations market capitalization stands at $2.073 billion, with a P/E ratio of 25.21 and a forward P/E of 19.27, indicating a relatively attractive valuation compared to industry peers. The companys return on equity (RoE) of 8.24% is respectable, considering the industrys capital-intensive nature. By combining the technical and fundamental analysis, we can forecast that ADUS will continue to experience steady growth, driven by the increasing demand for home care services and the companys diversified revenue streams. As the stock approaches the $117.40 resistance level, a breakout could potentially propel the price towards $130.00, representing a 14% upside from current levels.
Based on the analysis, our forecast is that Addus HomeCare Corporation will maintain its upward trajectory, driven by its strong service portfolio, diversified client base, and favorable industry trends. As the company continues to execute its growth strategy, we expect the stock to reach $125.00 by the end of the next quarter, representing a 9.6% upside from current levels. Investors should monitor the stocks price action around the $117.40 resistance level, as a breakout could lead to further upside potential.
Additional Sources for ADUS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ADUS Stock Overview
Market Cap in USD | 2,075m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2009-10-28 |
ADUS Stock Ratings
Growth Rating | 4.82 |
Fundamental | 53.0 |
Dividend Rating | 0.0 |
Rel. Strength | 4.1 |
Analysts | 4.45 of 5 |
Fair Price Momentum | 104.45 USD |
Fair Price DCF | 105.08 USD |
ADUS Dividends
Currently no dividends paidADUS Growth Ratios
Growth Correlation 3m | 94.1% |
Growth Correlation 12m | -58.6% |
Growth Correlation 5y | 33.9% |
CAGR 5y | 3.79% |
CAGR/Max DD 5y | 0.08 |
Sharpe Ratio 12m | 0.22 |
Alpha | -9.92 |
Beta | 0.406 |
Volatility | 44.36% |
Current Volume | 136k |
Average Volume 20d | 157.9k |
As of June 18, 2025, the stock is trading at USD 114.03 with a total of 136,016 shares traded.
Over the past week, the price has changed by -3.36%, over one month by +2.65%, over three months by +22.10% and over the past year by -3.12%.
Partly, yes. Based on ValueRay´s Fundamental Analyses, Addus HomeCare (NASDAQ:ADUS) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 52.96 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ADUS is around 104.45 USD . This means that ADUS is currently overvalued and has a potential downside of -8.4%.
Addus HomeCare has received a consensus analysts rating of 4.45. Therefor, it is recommend to buy ADUS.
- Strong Buy: 7
- Buy: 3
- Hold: 0
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, ADUS Addus HomeCare will be worth about 114.8 in June 2026. The stock is currently trading at 114.03. This means that the stock has a potential upside of +0.66%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 136.5 | 19.7% |
Analysts Target Price | 135.7 | 19% |
ValueRay Target Price | 114.8 | 0.7% |